Generali Investments CEE, investicni spolecnost, a.s.
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 2047540
PRAGUE, 2N
Position in ALNY
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$1,158,965
+$199,442 QoQ
Shares Held
3,850
+32.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#12
of 61 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Generali Investments CEE, investicni spolecnost, a.s. holds $13,946,368 across 8 Biotechnology names. ALNY ranks #4 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
10,599 | $5,264,841 | |
| 2 | SRPT |
Sarepta Therapeutics, Inc.
|
211,850 | $3,806,944 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,370 | $1,477,789 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
3,850 | $1,158,965 | |
| 5 | MRNA |
Moderna, Inc.
|
12,700 | $889,381 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
14,400 | $823,968 | |
| 7 | BNTX |
BioNTech SE
|
3,200 | $297,760 | |
| 8 | INCY |
Incyte Corp
|
2,000 | $226,720 |
All Filings in ALNY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,158,965 | 3,850 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $959,523 | 2,900 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $1,153,185 | 2,900 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,322,400 | 2,900 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $945,661 | 2,900 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $783,058 | 2,900 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $682,399 | 2,900 | Shares | Sole | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||